Peter Hammerer

4.1k total citations
86 papers, 2.6k citations indexed

About

Peter Hammerer is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Peter Hammerer has authored 86 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 22 papers in Rheumatology and 19 papers in Surgery. Recurrent topics in Peter Hammerer's work include Prostate Cancer Diagnosis and Treatment (64 papers), Prostate Cancer Treatment and Research (62 papers) and Urologic and reproductive health conditions (22 papers). Peter Hammerer is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (64 papers), Prostate Cancer Treatment and Research (62 papers) and Urologic and reproductive health conditions (22 papers). Peter Hammerer collaborates with scholars based in Germany, United States and Austria. Peter Hammerer's co-authors include Hartwig Huland, Markus Graefen, Joachim Noldus, Alexander Haese, Andreas Erbersdobler, Rolf‐Peter Henke, Edith Huland, Herbert Augustin, Jüri Palisaar and Dany‐Jan Yassin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Peter Hammerer

84 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hammerer Germany 32 2.0k 637 460 338 289 86 2.6k
Edith Canby‐Hagino United States 18 3.5k 1.8× 762 1.2× 689 1.5× 223 0.7× 346 1.2× 42 4.1k
Guillaume Ploussard France 34 2.5k 1.2× 772 1.2× 875 1.9× 381 1.1× 355 1.2× 112 3.2k
Paul Van Cangh Belgium 13 1.5k 0.7× 432 0.7× 418 0.9× 145 0.4× 140 0.5× 34 2.0k
Richard Choo United States 26 2.1k 1.0× 333 0.5× 651 1.4× 206 0.6× 163 0.6× 114 2.8k
Marian Loffredo United States 27 2.7k 1.4× 308 0.5× 441 1.0× 141 0.4× 269 0.9× 82 3.0k
Anders Angelsen Norway 24 1.3k 0.7× 312 0.5× 340 0.7× 441 1.3× 308 1.1× 45 2.0k
Philipp Mandel Germany 23 1.4k 0.7× 367 0.6× 395 0.9× 186 0.6× 165 0.6× 196 1.9k
I.D. Kaplan United States 17 1.5k 0.8× 199 0.3× 361 0.8× 657 1.9× 334 1.2× 47 2.4k
Robert Given United States 19 1.7k 0.9× 144 0.2× 401 0.9× 262 0.8× 474 1.6× 57 2.2k
Martin Spahn Germany 26 1.3k 0.7× 308 0.5× 803 1.7× 798 2.4× 970 3.4× 112 2.6k

Countries citing papers authored by Peter Hammerer

Since Specialization
Citations

This map shows the geographic impact of Peter Hammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hammerer more than expected).

Fields of papers citing papers by Peter Hammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hammerer. The network helps show where Peter Hammerer may publish in the future.

Co-authorship network of co-authors of Peter Hammerer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hammerer. A scholar is included among the top collaborators of Peter Hammerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hammerer. Peter Hammerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Steuber, Thomas, Isabel Heidegger, Felix K.‐H. Chun, et al.. (2021). PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer. European Urology Oncology. 5(3). 321–327. 13 indexed citations
3.
4.
Hammerer, Peter & Stephan Madersbacher. (2012). Landmarks in hormonal therapy for prostate cancer. British Journal of Urology. 110(s1). 23–29. 22 indexed citations
5.
Djavan, Bob, V. Ravery, Bernardo Rocco, et al.. (2007). European Study of Radical Prostatectomy: time trends in Europe, 1993–2005. British Journal of Urology. 100(s2). 22–25. 14 indexed citations
6.
Hammerer, Peter, Michael W. Kattan, Nicolas Mottet, & T. Prayer-Galetti. (2006). Using prostate‐specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer. British Journal of Urology. 98(1). 11–19. 6 indexed citations
7.
Augustin, Herbert, Andreas Erbersdobler, Peter Hammerer, Markus Graefen, & Hartwig Huland. (2004). Prostate cancers in the transition zone: Part 2; clinical aspects. British Journal of Urology. 94(9). 1226–1229. 40 indexed citations
8.
Augustin, Herbert, Peter Hammerer, Markus Graefen, et al.. (2003). Intraoperative and Perioperative Morbidity of Contemporary Radical Retropubic Prostatectomy in a Consecutive Series of 1243 Patients: Results of a Single Center between 1999 and 2002. European Urology. 43(2). 113–118. 127 indexed citations
9.
Augustin, Herbert, Peter Hammerer, Markus Graefen, et al.. (2003). Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy. Journal of Cancer Research and Clinical Oncology. 129(11). 662–668. 19 indexed citations
10.
Graefen, Markus, Pierre I. Karakiewicz, Ilias Cagiannos, et al.. (2002). A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urologic Oncology Seminars and Original Investigations. 7(4). 141–146. 59 indexed citations
11.
Noldus, Joachim, Uwe Michl, Markus Graefen, et al.. (2002). Patient-reported Sexual Function After Nerve-sparing Radical Retropubic Prostatectomy. European Urology. 42(2). 118–124. 113 indexed citations
12.
13.
Huland, Hartwig, Markus Graefen, Alexander Haese, et al.. (2002). Prediction of tumor heterogeneity in localized prostate cancer. Urologic Clinics of North America. 29(1). 213–222. 6 indexed citations
14.
Friedrich, Martin, Karin Milde‐Langosch, Andreas Erbersdobler, et al.. (2001). Frequent p16/MTS1 Inactivation in Early Stages of Urothelial Carcinoma of the Bladder Is Not Associated with Tumor Recurrence. European Urology. 40(5). 518–524. 37 indexed citations
15.
Friedrich, Martin, Sabine Riethdorf, Andreas Erbersdobler, et al.. (2001). Relevance of p53 Gene Alterations for Tumor Recurrence in Patients with Superficial Transitional Cell Carcinoma of the Bladder. European Urology. 39(2). 159–166. 30 indexed citations
16.
17.
Graefen, Markus, Peter Hammerer, Uwe Michl, et al.. (1998). Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology. 51(3). 437–442. 42 indexed citations
18.
Terris, Martha K., et al.. (1998). Comparison of ultrasound imaging in patients undergoing transperineal and transrectal prostate ultrasound. Urology. 52(6). 1070–1072. 16 indexed citations
19.
Noldus, Joachim, Peter Hammerer, Markus Graefen, & Hartwig Huland. (1997). Surgical therapy for localized prostatic carcinoma. Journal of Cancer Research and Clinical Oncology. 123(3). 180–184. 14 indexed citations
20.
Haese, Alexander, Markus Graefen, Joachim Noldus, et al.. (1997). PROSTATIC VOLUME AND RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATIC CANCER OR BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 158(6). 2188–2192. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edith Canby‐Hagino Breakdown of academic impact, for papers by Guillaume Ploussard Breakdown of academic impact, for papers by Paul Van Cangh Breakdown of academic impact, for papers by Richard Choo Breakdown of academic impact, for papers by Marian Loffredo Breakdown of academic impact, for papers by Anders Angelsen Breakdown of academic impact, for papers by Philipp Mandel Breakdown of academic impact, for papers by I.D. Kaplan Breakdown of academic impact, for papers by Robert Given Breakdown of academic impact, for papers by Martin Spahn
Rankless by CCL
2026